Important Update on Equity Sublingual NAD+* Our highly sought after Equity® NAD+ sublingual tablets are currently under reformulation. We anticipate them to be ready for purchase by the end of August 2025. This product RAW ® NAD+ powder is currently being used by our clients as a substitute for the Equity® or our Fusion® NAD+/NMN can